The pharmacology of respiratory depressants and stimulants.
This article reviews the pharmacology and respiratory actions of depressants and stimulants, and the use of these drugs in the management of dyspnea, respiratory failure, and sleep apnea syndrome.
D000086:Acetazolamide / Q000494:pharmacology; D015765:Almitrine; D014151:Anti-Anxiety Agents / Q000494:pharmacology; D001569:Benzodiazepines; D002492:Central Nervous System Depressants / Q000494:pharmacology*; D000697:Central Nervous System Stimulants / Q000494:pharmacology*; D000431:Ethanol / Q000494:pharmacology; D006801:Humans; D009294:Narcotics / Q000378:metabolism / Q000494:pharmacology; D010879:Piperazines / Q000494:pharmacology; D011374:Progesterone / Q000494:pharmacology; D012119:Respiration / Q000187:drug effects*; D012131:Respiratory Insufficiency / Q000188:drug therapy; D014970:Xanthines / Q000494:pharmacology
D014151:Anti-Anxiety Agents; D002492:Central Nervous System Depressants; D000697:Central Nervous System Stimulants; D009294:Narcotics; D010879:Piperazines; D014970:Xanthines; D001569:Benzodiazepines; C008514:methylxanthine; D000431:Ethanol; D011374:Progesterone; D015765:Almitrine; D000086:Acetazolamide